U.S. CDMRP – Duchenne Muscular Dystrophy Research Program (DMDRP) | Research Funding

Through the Congressionally Directed Medical Research Program (CDMRP), the Department of Defense is announcing the 2024 Duchenne Muscular Dystrophy Research Program (DMDRP). Several award programs are available:

• The Clinical/Translational Research Award supports advanced translational research that will accelerate the movement of promising ideas in DMD research into clinical applications. Translational research may be defined as an integration of basic science and clinical observations. However, applicants should not view translational research as a one-way continuum from bench to bedside. The research plan must involve a reciprocal flow of ideas and information between applied and clinical research. As such, applications must include preliminary and/or published data relevant to DMD to support the proposed research project.

• The Idea Development Award promotes new ideas that are still in the early stages of development and have the potential to yield impactful data and new avenues of investigation. This award supports conceptually innovative, high-risk/high-reward research that could lead to critical discoveries or major advancements that will accelerate progress in improving outcomes for individuals with DMD. Applications should include a well-formulated, testable hypothesis based on strong scientific rationale.

• Clinical/Translational Research Award: $650,000 – 1.5M
• Idea Development Award: $350,000

• Clinical/Translational Research Award: 3-4  years
• Idea Development Award: 2 years

• To find the full program announcements and to start your pre-application see here
• A useful summary of each call can be found here
• For questions about the eBRAP or Grants.gov platforms, contact the Research Office.
• Grants.gov Funding Opportunity Numbers:
  • Clinical/Translational Research Award: HT942524DMDRPCTRA
  • Idea Development Award: HT942524DMDRPIDA